Table 3.
Multivariate regression of Barriers to Healthy Eating and Barriers to Physical Activity on Demographics, Quality of Life, Symptoms, and Cancer Treatment
| Predictors | Model 1: BHE | Model 2: BPA | ||
|---|---|---|---|---|
| R2=0.21 | R2=0.34 | |||
| Coef (SE) | P-value | Coef (SE) | P-value | |
| Current Age | −0.004 | 0.61 | −0.01 | 0.26 |
| Ethnicity (white vs. not white) | 0.008 | 0.94 | 0.10 | 0.36 |
| Has Children (yes vs. no) | 0.03 | 0.79 | 0.12 | 0.30 |
| Married or living as married (yes vs. no) | 0.001 | 0.99 | 0.11 | 0.33 |
| Four year college grad or more (yes vs. no) | −0.24 | 0.02 | −0.09 | 0.38 |
| Comorbid conditions (yes vs. no) | −0.05 | 0.60 | −0.15 | 0.18 |
| Had radiation only (yes vs. no) | −0.01 | 0.94 | 0.28 | 0.19 |
| Had chemotherapy only (yes vs. no) | −0.25 | 0.10 | −0.14 | 0.40 |
| Had both radiation and chemotherapy (yes vs. no) | −0.09 | 0.53 | 0.21 | 0.16 |
| Currently receiving endocrine therapy (yes vs. no) | −0.007 | 0.94 | 0.07 | 0.47 |
| Perceived Stress | 0.02 | 0.03 | 0.01 | 0.15 |
| Level of fatigue on the day most fatigue of past week | 0.02 | 0.34 | 0.02 | 0.30 |
| BCPT Bladder Control | 0.17 | 0.01 | ||
| BCPT Weight Problems | 0.13 | 0.002 | 0.07 | 0.15 |
| Physical Component Well-Being | 0.004 | 0.44 | −0.02 | 0.003 |
Additional Scale and item descriptions: Currently receiving endocrine therapy: e.g. Tamoxifen, Femara, Aromasin, Arimidex, Lupron or Zoladex; Stress: Perceived Stress Scale; Physical Component Well-Being: Short Form Health Survey (SF-12); Level of Fatigue: FSI; Breast Cancer-Related Symptoms: Breast Cancer Prevention Trial Symptom Checklist ,BCPT Symptom Scales